A
Aerin Medical
Health technology company that develops therapeutic devices to improve nasal breathing
About Aerin Medical
Aerin Medical is a healthcare startup that provides innovative, non-invasive solutions for patients suffering from nasal airway obstruction and chronic rhinitis. The company operates in the medical device market, specifically targeting patients with non-allergic and allergic rhinitis in the United States.
Aerin Medical's primary offerings are two devices, VivAer and RhinAer, which are used to deliver precise, temperature-controlled radiofrequency (RF) treatments. These treatments are designed to remodel soft tissue in the nasal valve, addressing the core causes of nasal airway obstruction without altering patient aesthetics. The procedures are incisionless and can be performed under local anesthesia, making them office-friendly solutions.
The VivAer device is used for treating nasal airway obstruction, while the RhinAer device is used for chronic rhinitis. Both devices are designed to fit seamlessly into a doctor's office or operating room, providing a convenient solution for physicians.
Aerin Medical's business model is based on selling these devices to healthcare providers. The company generates revenue through the sale of the devices and possibly through ongoing service and maintenance contracts.
In summary, Aerin Medical is a promising healthcare startup providing non-invasive, efficient, and effective solutions for patients suffering from nasal airway obstruction and chronic rhinitis.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Mountain View, United States
- Employees
- 156
- Open positions
- 4
- Dealroom signal
- 72.8/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Chronic Disease, Non-Invasive medical devices and treatments, Tech for Patients, Biotech and Pharma, Hard Tech
- Technology
- Hardware, Deep Tech, Connected Device
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jan 2025 | $33M | $300M | OrbiMed · Ally Bridge Group · Ares Management · KCK | ↗ |
| LATE VCOther financing | Jun 2022 | $60M | $240M | KCK · OrbiMed · Ally Bridge Group · Questa Capital Management | ↗ |
Growth signals
Latest recorded traffic for Aerin Medical is 3.8K monthly website visits, up 35.7% over the last three months. Aerin Medical's team declined 3.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
LaunchCapital
Series B and later7 investors entered at this stage
- TFTargeted Technology Fund
Horizon Technology Finance Corporation
Questa Capital Management
KCK
OrbiMed
Ally Bridge Group
Ares Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aerin Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aerin Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.